The growth inhibitory effect of p21 adenovirus on human bladder cancer cells

Journal of Urology

Volumn 163, Issue 3, 2000, Pages 1033-1038

  Craig Hall, M ^a   Li, Yingming ^a   Pong, Rey Chen ^a   Ely, Brent ^a   Sagalowsky, Arthur I ^a   Hsieh, Jer Tsong ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bladder cancer; Gene therapy; p21 protein

Indexed keywords

GROWTH INHIBITOR;

ARTICLE; BLADDER CANCER; CANCER CELL; CYTOMEGALOVIRUS INFECTION; GENE THERAPY; GROWTH INHIBITION; HUMAN; HUMAN ADENOVIRUS 2; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; VIRUS INFECTION;

EID: 0033975549     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)67877-9     Document Type: Article

References (21)

1. Landis, S. H., Murray, T., Bolden, S. and Wingo, P. A.: Cancer Statistics, 1998. CA Cancer J Clin, 48: 6, 1998
2. Spruck, C. H., Ohneseit, P. F., and Gonzale-Zulueta, M.: Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res, 54: 784, 1994
3. Ishikawa, J., Xu, H-J., Hu, S-X., Yandell, D. W., Maeda, S., Kamidono, S. and Benedict, W. F.: Inactivation of the retinoblastoma gene in human bladder and renal cell carcinoma. Cancer Res, 51: 5736, 1991
4. Presti, J. C., Reuter, V. E., Galan, T., Fair, W. R. and Cordon-Cardo, C.: Molecular genetic alterations in superificial and locally advanced human bladder cancer. Cancer Res, 51: 5405, 1991
5. Cordon-Cardo, C., Wartinger, D., Petrylak, D., Dalbagni, G., Fair, W. R., Fuks, Z. and Reuter, V. E.: Altered expression of the retinoblastoma gene product is a prognostic indicator of bladder cancer. J Natl Cancer Inst, 85: 1251, 1992
6. Logothetis, C. J., Xu, H-J., Ro, J. Y., Hu, S. X., Sahin, A., Ordonez, N. and Benedict, W. F.: Altered retinoblastoma protein expression in known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst, 85: 1256, 1992
7. Vogelstein, B. and Kinzler, K.: p53 function and dysfunction. Cell, 70: 523, 1992
8. Sidranksy, D., von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R. and Frost, P.: Identification of the p53 gene mutations in bladder cancer and urine samples. Science, 252: 706, 1991
9. Sarkis, A. S., Dalbagni, G., Cordon-Cardo, C., Melamed, J., Zhang, Z. F., Sheinfeld, J., Fair, W. R., Herr, H. W. and Reuter, V. E.: Nuclear over expression of p53 protein in transitional cell carcinoma: A marker for disease progression. J Natl Cancer Inst, 85: 53, 1993
10. Esrig, D., Elmajian, D., Groshen, S., Freeman, J. A., Stein, J. P., Chen, S. C., Nichols, P. W., Skinner, D. G., Jones, P. A. and Cote, R. J.: Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med, 331: 1259, 1994
11. El-Diery, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B.: WAF 1, a potential mediator of p53 tumor suppression. Cell, 75: 817, 1993
12. 1 cyclin-dependent kinases. Cell, 75: 805, 1993
13. Zhang, W., Grosso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A. B. and Mercer, W. E.: p53-independent induction of WAF 1/CIP 1 in human leukemia cells is correlated with gross arrest accompanying monocyte/ macrophage differentiation. Cancer Res, 55: 668, 1995
14. WAF1/CIP1 expression and tumor progression in bladder cancer. J Urol, 157(suppl): 161A, 1997
15. WAF1/CIP1 mutation in superficial and invasive transitional cell carcinoma. Oncogen, 13: 1831, 1996
16. Camps, J. L., Chang, S. M., Hsu, T. C., Freeman, M. R., Hong, S. J., Zhau, H. E., von Eschenbach, A. C. and Chung, L. W. K.: Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci USA, 81: 75, 1990
17. Tseng, C-P., Ely, B., Pong, R-C., Li, Y. and Hsieh, J. T.: Regulation of the DOC-2 gene during castration-induced rat ventral prostate degeneration and its growth inhibitory function in human prostatic carcinoma cells. Endocrinology, 139: 3542, 1998
18. Kleinerman, D., Diney C., Zhang, W. W., Lin S-H., Van, N. T. and Hsieh, J. T.: Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Cancer Res, 56: 3431, 1996
19. Li, Y., Pong, R. C., Hall, M. C., Sagalowsky A., Tseng, C-P., Wang, Z. Bergelson J. and Hsieh, J. T.: Loss of adenoviral receptor expression in human bladder cancer cells- A potential impact on the efficacy of gene therapy. Cancer Res, 59: 325, 1999
20. Makri, D., Schulz, W. A., Grimm, M., Clasen S., Bojar, H. and Schmitz-Drager, B. J.: WAF1/p21 regulates proliferation, but does not mediate p53-dependent apoptosis in urothelial carcinoma cell lines. Int J Cancer, 12: 621, 1998
21. Clasen S., Schulz, W. A., Gerharz, C. D., Grimm, M. O., Christoph, F. and Schmitz-Drager, B. J.: Freguent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma. Br J Cancer, 77: 515, 1998